~~<i id='8057E06AFD'><strike id='8057E06AFD'><tt id='8057E06AFD'><pre id='8057E06AFD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

focus

author：comprehensive 2025-09-06 04:30:47 - browse：4382

AP/Richard Drew

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.

The deal, disclosed as the biopharma field marked the first day of the annual J.P. Morgan Healthcare Conference, extends a recent spate of pharma acquisitions, contributing to hopes that 2024 could be a better year for the industry.

Under the agreement, J&J will pay $28 per share in cash for Ambrx, roughly a 100% premium to the latter’s recent trading price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

explore

Wikipedia

explore

leisure time

Wikipedia

entertainment

DavidL.Ryan/TheBostonGlobeStewardHealthCare’sMassachusettshospitalsareonthebrinkoffinancialdisaster.

WSS

The Bio Revolution is changing business and society

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Achieving telehealth equity for people with hearing loss

Pharma’s losing bet in New Jersey

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Protect nursing home residents from future pandemics

knowledge

focus

explore

Jerome Adams on the need for new antivirals for Covid

Ozempic cut risk of death in diabetes patients with chronic kidney disease

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Some medical students still think black patients feel less pain

After affirmative action ruling, medical educators look to 'holistic review'

Stroke rates rising, especially in working

Virginia high school admissions case could be legal follow

Ebola: Gilead Sciences antiviral shows promise as new treatment

Sports medicine is finally prioritizing gender equality

RaDonda Vaught links Vanderbilt hospital issues to patient death

Wikipedia

Clinicians often fail to acknowledge the pain caused by long Covid

Steward Health Care Massachusetts hospitals face fiscal disaster

Stroke rates rising, especially in working

EPA limits use of carcinogenic gas for sterilizing medical devices

Medicare coverage of Wegovy, once blocked, now looks possible

Some medical students still think black patients feel less pain

explore

leisure time

Wikipedia

entertainment